EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Feasibility of Patient-Derived 3D Gastrointestinal Stromal Tumour Models as Alternatives for In Vivo Mouse Models

Dina Mönch iD, Julia Thiel iD, Meng Dong iD, Annika Maaß iD, Eileen Wegner, Anna Binner, Annette M Staiger, Katrin S Kurz iD, German Ott, Philipp Renner, Tobias Leibold, Christian Schmees und 4 weitere

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262311456 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Dina Mönch und 15 weiteren Autor:innen. Beteiligte Einrichtung: Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, 70376 Stuttgart, Germany. Hauptthemen laut MEDLINE: Gastrointestinal Stromal Tumors, Gastrointestinal Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Robert-Bosch Stiftung, Ministry of Science, Research and Arts Baden-Württemberg, German Federal Ministry of Education and Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gastrointestinal stromal tumours (GISTs) are the most common mesenchymal tumours of the gastrointestinal tract and a key example for targeted therapy with tyrosine kinase inhibitors (TKIs), which have significantly improved survival rates. However, no effective treatments exist for TKI-resistant or mutation-negative tumours. Until now, research on the effects of TKIs has mainly used 2D cultures or mouse models, lacking patient-specific 3D GIST models. We investigated various 3D GIST models, including spheroids, organoids, patient-derived microtumours (PDMs), and precision-cut tumour slices (PCTSs), to assess their feasibility as alternatives for 2D cell culture or in vivo mouse models. Moreover, 2D monolayer and 3D spheroid GIST cell lines showed mutation-dependent responses to TKI treatment, but differences between 2D and 3D cultures were minimal. Thus, patient-derived 3D models, incorporating tumour microenvironment cells, were developed for more accurate in vivo representation. PDMs and PCTSs were successfully isolated from primary tumours and cultivated for up to two weeks. Three-dimensional models were immunohistochemically characterised, and the response to TKI therapies was tested and compared with expected clinical outcomes. In addition to already established 2D cell cultures and mouse models, PDMs and PCTSs are novel patient-derived 3D models that can be used to study tumour cell interactions within the microenvironment. Moreover, they could be used to investigate TKI resistance, and novel treatment options such as immunotherapies and combination therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal Stromal TumorsGastrointestinal NeoplasmsAnimalsMiceHumansSpheroids, CellularOrganoidsDisease Models, AnimalCell Line, TumorTumor MicroenvironmentProtein Kinase InhibitorsCell Culture TechniquesFeasibility Studies

Stichwörter der Autor:innen

gastrointestinal stromal tumourspatient-derived 3D modelstumour microenvironment

Substanzen

Protein Kinase Inhibitors

Autor:innen und Institutionen

  • Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, 70376 Stuttgart, Germany.
  • University of Tübingen, 72074 Tübingen, Germany.
  • German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 72076 Tübingen, Germany.
  • NMI Natural and Medical Sciences Institute, University of Tübingen, 72770 Reutlingen, Germany.
  • Department of Clinical Pathology, Robert-Bosch-Hospital, 70376 Stuttgart, Germany.
  • Department of General and Visceral Surgery, Robert-Bosch-Hospital, 70376 Stuttgart, Germany.

ORCID-Profile: Dina Mönch, Julia Thiel, Meng Dong, Annika Maaß, Katrin S Kurz, Thomas E Mürdter, Matthias Schwab, Jana Koch

Förderung

  • Robert-Bosch Stiftung
  • Ministry of Science, Research and Arts Baden-Württemberg
  • German Federal Ministry of Education and Research

Zitieren

APA

Mönch, D., Thiel, J., Dong, M., Maaß, A., Wegner, E., Binner, A., Staiger, A. M., Kurz, K. S., Ott, G., Renner, P., Leibold, T., Schmees, C., Mürdter, T. E., Schwab, M., Dahlke, M. H., & Koch, J. (2025). Feasibility of Patient-Derived 3D Gastrointestinal Stromal Tumour Models as Alternatives for In Vivo Mouse Models. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262311456

Vancouver

Mönch D, Thiel J, Dong M, Maaß A, Wegner E, Binner A, et al. Feasibility of Patient-Derived 3D Gastrointestinal Stromal Tumour Models as Alternatives for In Vivo Mouse Models. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262311456

BibTeX
@article{Mnch2025,
  author = {Mönch, Dina and Thiel, Julia and Dong, Meng and Maaß, Annika and Wegner, Eileen and Binner, Anna and Staiger, Annette M and Kurz, Katrin S and Ott, German and Renner, Philipp and Leibold, Tobias and Schmees, Christian and Mürdter, Thomas E and Schwab, Matthias and Dahlke, Marc-H and Koch, Jana},
  title = {Feasibility of Patient-Derived 3D Gastrointestinal Stromal Tumour Models as Alternatives for In Vivo Mouse Models},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262311456}
}
Kostenlos starten →